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Abstract 
Objective: One of the most important causes of nosocomial infections is Staphylococcus aureus. The aim of this study 
was to determine the frequency of these genes and the rate of expression of these genes during nasal colonization 
among the personnel of Kashani and Hajar hospitals.
Results: In this Analytical-descriptive study, 240 nasal swab specimens were collected from personnel of different 
departments of Kashani and Hajar hospitals in Shahr-e-kord. Nasal specimens were cultured and 110 Staphylococ-
cus strains were isolated. Based on the results, 110 carriers of Staphylococcus aureus were identified. The frequency of 
clfA, clfB, fnbA and fnbB genes were 36.3%, 86.3%, 7.2% and 43.6% respectively. It was also observed that the fnbA 
gene showed no expression, but of 95 clfB-positive samples, 73 isolates (76.8%) were expressed clfB gene. This study 
showed that the abundance of these genes varies in nasal colonization. It was also observed that clfB gene with a 
high frequency and high expression rate has an important role in nose colonization. These results not only provide 
insight into the factors involved in S. aureus colonization but also provide potential therapeutic targets.
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Introduction
Staphylococcus aureus is an important human pathogen 
and is colonized in skin and mucous membrane. This 
bacterium is permanently colonized in 20% of healthy 
adults in nose and skin [1]. People who are predisposed to 
nasal colonization with S. aureus are at the risk of infec-
tions such as mild skin and soft tissue infections, and also 
more serious diseases such as endocarditis, bacteremia, 
and sepsis [2, 3]. For many years, this bacterium has been 
considered a main hospital pathogen. It causes a wide 
range of epidermal infections, septicemia, endocarditis, 
and pneumonia that are life-threatening [4]. Important 
bacterial virulence factors are surface factors that cause 
bacteria to adhere and colonize at the surfaces. These 
specific adhesive agents can bind to a variety of host pro-
teins, particularly those in the extracellular matrix (ECM), 
and also to the host cells. This binding is mediated by a 
family of proteins called microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs) 
[5, 6]. S. aureus can express various MSCRAMMs includ-
ing clfA, clfB, fnbA, fnbB, fib, Eno, can, ebps, and bbp [7, 
8]. ClfA (Clumping Factor A) is a staphylococcal fibrino-
gen-binding protein that is responsible for the accumula-
tion of this bacterium in the blood plasma and plays an 
important role in arthritis and endocarditis. This fac-
tor also binds to platelets [9]. The ability of S. aureus to 
bind to and colonize in the nasal epithelium is due to the 
expression of the clfB surface protein [10]. Fibronectin-
binding proteins (FnbA and FnbB) are effective in tissue 
invasion in various pathological conditions such as eye 
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keratitis, osteomyelitis, and replacement at the surfaces 
of medical devices. FnbA/B is also a mediator of signal-
ing cell and actin cytoskeletal rearrangement [11]. The 
adhesion gene fnbA leads to cardiovascular disease and 
cardiovascular system infection through platelet activa-
tion and also causes adhesions to artificial implants in the 
body [5]. The identification of the genes involved in colo-
nization has attracted the researchers’ attention [6]. The 
aim of this study was to compare the prevalence of clfA, 
clfB, fnbA, fnbB genes involved in colonization, as well as 
to compare the expression patterns of the clfB and fnbA 
genes.
Main text
Materials and methods
Specimen collection and isolation and identification 
of bacteria
In this analytical-descriptive study, 240 nasal swab speci-
mens were collected from the staff of different wards of 
Kashani and Hajar Teaching hospitals in Shahrekord. The 
swabs were immediately transferred to the TSB broth 
environment and incubated for 24 h. Then, S. aureus iso-
lates were identified by performing tests such as hot dye-
ing, colony morphology, and various biochemical tests 
such as colony morphology, catalase activity, mannitol 
salt agar, coagulase test, and DNase test.
DNA extraction and RNA extraction and cDNA synthesis
DNA extraction was performed by boiling method. 
Sterile swabs were wetted with 250 μl of nucleoside and 
specimens were taken from the anterior nasal cavity of 
the participants. Subsequently, the swab was placed in 
1000  μl of Trizole and RNA extraction was performed 
according to the Trillocentrum protocol. Then, 1000  ng 
of RNA was used for the synthesis of cDNA by using 
RevertAid First Strand cDNA Synthesis Kit.
PCR
In this study, specific primers were designed to confirm 
the presence of the clfA, clfB, fnbA, and fnbB genes, as 
well as measuring the expression of the clfB and fnbA 
genes. Also a primer pair was designed for the reference 
gene. The characteristics of the primers are shown in 
Table 1.
The PCR conditions included an initial denaturation 
at 95  °C for 7  min, followed by a 35-cycle amplification 
consisting of denaturation at 95  °C for 45  s, annealing 
for 20 s and extension at 72 °C for 30 s followed by final 
extension at 72 °C for 1 min. After completing the PCR, 
the PCR product was tested for the bands and the pres-
ence of the genes of interest on a 8% polyacrylamide gel. 
The annealing temperature for clfA, clfB, fnbA, fnbB, and 
16S rRNA genes was 57 °C, 57 °C, 56 °C, 59 °C, and 58 °C, 
respectively.
Real‑time
In order to perform Real-time PCR, 6  µl SYBR™ Green 
Master (TAKARA), 4  µl of nuclease–free water, 1  µl of 
cDNA, and 0.5 µl of primer of the desired gene at a con-
centration of 5 pM were added into Real-time tube caps. 
According to the temperature cycling program, the tube 
caps were placed in the Real-time PCR instrument to 
measure the mRNA expression of clfB and fnbA genes 
with 16S rRNA as internal control [12]. The Real- time 
PCR conditions included an initial denaturation at  95º C 
for 10 min, followed by a 40-cycle amplification consist-
ing of denaturation at 95  °C for 10 s, annealing at 60  °C 
for 20 s and extension at 72 °C for 30 s followed by Melt-
ing curves to verify qPCR product identity.
Statistical analysis
Statistical analysis were determined by the exact fisher 
and  K2 test, using IBM SPSS Statistics 20software dif-
ferences were considered significant if P values were less 
than 0.05.
Results
Investigating the relationship between the gene 
and the parts of the hospital by the method PCR
In this study, 240 swabs of nose of personnel of Hajar 
and Kashani hospitals were obtained and 110 samples of 
Staphylococcus aureus were positive (45%) including 53 
samples from Hajar Hospital and 57 from Kashani Hos-
pital. The frequency of clfA, clfB, fnbA and fnbB genes 
were observed (36.3%), (86.3%), (7.2%), and (43.6%) 
respectively. The highest frequency of clfA gene was 
observed in ICU (69.2%) and operating room (54.5%). 
ClfB gene was highly prevalent in most parts. The highest 
frequency of fnbB gene was found in the operating room 
Table 1 Specifications of designed primers
Gene Primer sequence(5′ to 3′) Product 
length (bp)
fnbAF TGG TAC TGA TGA AGT TGA TTT TAG AAC 101
fnbAR CAT TAT CCC AAG TTA AGG TAT ATC CTC 
clfBF CCG GTA GTA AAT GCT GCT GTA 103
clfBR CAC TTT GAT TAG GGT CAA ATG TAG TC
16sF GGT CTG TAA CTG ACG CTG ATGTG 68
16sR GTG GAC TAC CAG GGT ATC TAA TCC T
fnbBF GGA GCG GCC TCA GTA TTC TT 201
fnbBR AGT TGA TGT CGC GCT GTA TG
clfAF CGC CGG TAA CTG GTG AAG CT 314
clfAR TGC TCT CAT TCT AGG CGC ACTT 
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(90.9%) and pediatrics (87.5%). FnbA gene had a low fre-
quency in most parts. The relationship between the gene 
and the part of hospital is shown in Table 2.
Results of real time and investigating the expression of clfB 
and fnbA genes
Out of 110 positive samples of Staphylococcus aureus, 
8 samples contained the fnbA gene with no expression 
patterns. Of 95 samples contained clfB gene, 71 sam-
ples showed gene expression. The highest expression of 
the gene was related to bacteria isolated from the pedi-
atric ward (100%) and the lowest expression of the gene 
belonged to the bacteria isolated from the dialysis section 
(50%). The average of clfB gene expression in each hospi-
tal segment is shown in Fig. 1.
Discussion
Staphylococcusaureus is an important hospital pathogen, 
the most common cause of surgical wound infections, 
the second leading cause of hospital pneumonia, and 
also responsible for 35% of hospital-acquired bacteremia 
[3]. Among the many virulence factors of this bacterium, 
MASCRAMMs; responsible for the bacterial adhe-
sion to the host, are more important [13]. In the current 
study, the coding genes for clfA and clfB, as well as the 
coding genes for the fibronectin-binding proteins A and 
B were investigated. In a total of 110 positive S. aureus 
specimens taken from the 10 wards of Hajar and Kashani 
Hospitals, the frequency of the clfA, clfB, fnbA, and 
fnbB genes was 36.3%, 86.3%, 7.2%, and 43.6%, respec-
tively. The highest frequency in all wards was observed 
for the clfB gene with only 5 isolates lacking this gene. 
The lowest frequency was obtained for the fnbA gene 
with only 8 isolates containing this gene. S. aureus binds 
to cytokeratin 10 on epithelial cells with the help of the 
clfB, which increases the ability of the bacterium to bind 
and colonize, especially in the nose. For example, a study 
by Palmqvist et  al. on Staphylococcal arthritis and sys-
temic inflammation which 92% of the samples contained 
clfB gene, showed that clfB is involved in inducing local 
arthritis, as well as cartilage and bone destruction [14]. 
In another study by Salman sahab, Atshan et  al. on 60 
clinical specimens, all specimens were found to contain 
the clfB gene, and in a similar study on 36 clinical speci-
mens, by Ghasemian et  al. 100% of the specimens con-
tained the clfB gene. In addition, in a study of 70 isolates 
from the people with bone infections by Rohde et al., the 
frequency of the clfB gene was reported to be 100% [6, 
15, 16]. In a study by Ewa szczuka et al. which different 
clinical samples were collected over a period of 4 years, 
the results showed that the frequency of clfB gene in the 
Table 2 Investigating the relationship between the gene and the parts of the hospital
* In the table, the values for the presence of the gene are in the relevant section. P-value <0.05
Parts fnbB
Number (%)
fnbA
Number (%)
clfB
Number (%)
clfA
Number (%)
Total
Number (%)
Infectious 45.4 (5) 0 (0) 10 (83.3) 4 (33.3) 12
Dialysis 45.4 (5) 2 (18.1) 10 (90.9) 4 (36.3) 11
Pediatrics 87.5 (7) 0 (0) 7 (87.5) 4 (50) 8
Surgery room 90.9 (10) 1 (9.09) 9 (81.8) 6 (54.5) 11
CCU 27.2 (3) 0 (0) 10 (90.9) 2 (18.1) 11
Men’s surgery 25 (3) 0 (0) 8 (66.7) 3 (25) 12
Women’s orthopedic 18.1 (2) 1 (9.09) 10 (90.9) 4 (36.3) 11
Men’s orthopedic 27.2 (3) 0 (0) 10 (90.9) 3 (27.2) 11
Burns 0 (0) 0 (0) 9 (90) 1 (10) 10
ICU 76.9 (10) 4 (30.7) 12 (3.92) 9 (69.2) 13
P-value 0.026* 0.042* 0.006* 0.026* 110
Fig. 1 The average of clfB gene expression in each hospital segment. 
The average of clfB gene expression was compared in different parts 
of the population and there was no significant difference between 
the sections. P-value = 0.288
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isolates from patients with pneumonia was 97% and in 
those from patients with bacteremia, bone infection, skin 
and surface tissue infections, otitis media, and arthri-
tis was 100% [17]. The results of all studies and the high 
prevalence of clfB gene indicated the remarkable role 
of this gene in the pathogenicity of S. aureus, as well as 
bacterial colonization at various surfaces. The results 
of our study are consistent with the results of the cited 
studies and confirms the role of this gene in the coloniza-
tion in healthy individuals and patients. ClfA is also one 
of the bacterial virulence factors that bind to fibrinogen 
and contribute to arthritis and endocarditis, and can 
contribute to the accumulation of bacteria in the blood 
plasma [18]. In a study by Arciola on samples isolated 
from orthopedic infections, the frequency of the fnbA 
gene was 98% and the 99% fnbB gene was observed [19]. 
The influence of the clfA and fnbA genes on the patho-
genicity of S. aureus in ear infections has been reported, 
with the frequency of 32% and 76%, respectively [20]. To 
determine the role of each of the clfB and fnbA genes 
in the colonization of S. aureus in healthy individuals, 
the expression of each of these genes was measured by 
Real-time PCR. Due to the high frequency of cytokera-
tin 10 receptors in the nose [21, 22] to which S. aureus 
binds to by clfB, the clfB gene expression is expected, 
as with its frequency, to be high. In our study, of the 95 
clfB gene-containing specimens, 76.8% were observed to 
be expressed and none of the 8 samples containing the 
fnbA gene showed expression. The results obtained in 
this study suggest that S. aureus activates the clfB gene 
via its transcription and thus causes the bacterium to 
adhere to the nasal epithelial cells and colonize in there. 
Studies have shown that in addition to clfB, teichoic acid 
and isdA also play an important role in the binding and 
colonization of the nasal bacteria [23]. In a study by Jen-
kinz et al. on S. aureus-infected mice, fnbA gene expres-
sion was shown to increase during nasal colonization 
and in bacteremia and thromboembolic lesions [24]. 
On the other hand, other studies have shown that fnbA 
and TagO play a key role in binding to endothelial cells, 
which can indicate the comparatively less pronounced 
role of these genes in binding to epithelial cells [25–27]. 
Therefore, the results of this study are consistent with the 
results of the cited studies, indicating the role of the fnbA 
gene in the nasal colonization in vivo. In the study of Bur-
ian et al. on S. aureus samples during nasal colonization, 
the expression of the clfB gene was observed to increase 
[21]. This information on these issues can help to bet-
ter understand the pathogenicity and also facilitation of 
the control and prevention of Staphylococcal infections. 
The inconsistency in the results of the present study and 
other studies regarding the expression of clfB and fnbA 
genes can be explained by the fact that clfB gene plays a 
comparatively more important and reportedly definite 
role in nasal colonization.
Limitations
The lack of investigation and characterization of other 
virulence factors in Staphylococcus aureus isolates can be 
mentioned as one of the main limitations of the present 
study.
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